Raymond James hires veteran senior medical technology banker, continuing Healthcare Investment Banking practice momentum
ST. PETERSBURG, Fla. – Raymond James has hired seasoned investment banker Jed Cohen as a managing director in the firm’s Healthcare Investment Banking practice. The strategic hire underscores the firm’s continuing commitment to expanding the sector-specific capabilities within its Healthcare group, which has now added 14 senior bankers since August 2022.
Based in New York, Cohen has nearly 30 years of experience in the healthcare investment banking industry. He will work with clients in the medical technology sector, providing financial and strategic advice to facilitate their growth.
“Our goal with each new hire is to add another area of sector specialization to create a comprehensive healthcare practice able to serve the entire healthcare economy and deliver invaluable insights and essential guidance for our clients,” said Doug Brown, senior managing director and head of Healthcare Investment Banking. “Jed Cohen, whom I have known for 25 years and worked with at his two previous firms, brings another area of expertise for our healthcare clients with his deep knowledge of the medical technology industry. Importantly, Jed’s arrival allows us to enhance our services for the venture capital and growth equity communities, which increasingly value sector expertise to identify new investment opportunities and grow their portfolio companies.”
Cohen joins Raymond James from SVB Securities/Leerink Partners, where he held the position of senior managing director of medical technology investment banking since 2009. His professional background includes 12 years at Citigroup and three years at UBS. Cohen brings a breadth of medical technology transaction experience to Raymond James, having executed over 100 M&A and equity financing transactions in the medical technology sector. He is a graduate of the University of Pennsylvania’s Wharton School with a Bachelor of Science degree in economics.
“I am thrilled to join a healthcare practice deeply dedicated to serving innovative businesses in the ever-changing medical technology sector, and I eagerly look forward to contributing my specialized knowledge to further enhance their coverage,” said Cohen. “My approach of being a trusted advisor on the company-building journey with a long-term relationship focus matches perfectly with the philosophy of Raymond James.”
Operating as a cohesive unit, the Raymond James healthcare team serves middle-market and growth-oriented healthcare clients in the healthcare services, life sciences services, biotechnology and medical technology sectors.
About Raymond James Investment Banking
Raymond James Investment Banking offers highly regarded capital formation and financial advisory services. Since 2018, we have participated in raising over $180 billion in capital for our U.S. corporate clients and completed more than 1,040 M&A and other strategic advisory assignments, including over 855 M&A advisory assignments. Raymond James & Associates, Inc., member New York Stock Exchange/SIPC.
About Raymond James Financial, Inc.
Raymond James Financial, Inc. (NYSE: RJF) is a leading diversified financial services company providing private client group, capital markets, asset management, banking and other services to individuals, corporations and municipalities. The company has approximately 8,700 financial advisors. Total client assets are $1.23 trillion. Public since 1983, the firm is listed on the New York Stock Exchange under the symbol RJF. Additional information is available at raymondjames.com. Past performance is not indicative of future results. The information provide is for informational purposes only and is not a solicitation to buy or sell Raymond James Financial Stock.